Gene · 11082
Papers2,013
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,013
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gelanxinning capsule improves coronary microvascular dysfunction by inhibiting inflammation and restoring endothelial function. | Eur Rev Med Pharmacol Sci | 2023 | 37782173 | PubTator, text mining | PubMed |
| Persistent Endothelial Lung Damage and Impaired Diffusion Capacity in Long COVID. | J Pers Med | 2023 | 37763119 | PubTator, text mining | PubMed |
| Advances in Histological and Molecular Classification of Hepatocellular Carcinoma. | Biomedicines | 2023 | 37761023 | PubTator, text mining | PubMed |
| Understanding yellow fever-associated myocardial injury: an autopsy study. | EBioMedicine | 2023 | 37757571 | PubTator, text mining | PubMed |
| Early Diagnostic Markers of Late-Onset Neonatal Sepsis. | Pediatr Rep | 2023 | 37755410 | PubTator, text mining | PubMed |
| A multi-omics study to investigate the progression of the Correa pathway in gastric mucosa in the context of cirrhosis. | Gut Pathog | 2023 | 37752551 | PubTator, text mining | PubMed |
| Tridepsides as potential bioactives: a review on their chemistry and the global distribution of their lichenic and non-lichenic natural sources. | Front Fungal Biol | 2023 | 37746133 | PubTator, text mining | PubMed |
| Incongruence between transcriptional and vascular pathophysiological cell states. | Nat Cardiovasc Res | 2023 | 37745941 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals That Adaptation of Human Aortic Endothelial Cells to Antiproliferative Therapies Is Modulated by Flow-Induced Shear Stress. | Arterioscler Thromb Vasc Biol | 2023 | 37732484 | PubTator, text mining | PubMed |
| Novel inflammatory biomarkers in the prognosis of COVID-19. | Ther Adv Respir Dis | 2023 | 37727063 | PubTator, text mining | PubMed |
| Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction. | J Transl Med | 2023 | 37726803 | PubTator, text mining | PubMed |
| Novel specific anti-ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis. | Cancer Sci | 2023 | 37715566 | PubTator, text mining | PubMed |
| Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape. | J Exp Clin Cancer Res | 2023 | 37697332 | PubTator, text mining | PubMed |
| High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints. | NPJ Precis Oncol | 2023 | 37696903 | PubTator, text mining | PubMed |
| Investigation of maternal serum endocan concentrations in pregnant women with gestational diabetes mellitus; a prospective case-control study. | J Matern Fetal Neonatal Med | 2023 | 37691263 | PubTator, text mining | PubMed |
| Perspectives of circular RNAs in diabetic complications from biological markers to potential therapeutic targets (Review). | Mol Med Rep | 2023 | 37681455 | PubTator, text mining | PubMed |
| Transcriptional immunogenomic analysis reveals distinct immunological clusters in paediatric nervous system tumours. | Genome Med | 2023 | 37679810 | PubTator, text mining | PubMed |
| Serum Endocan Levels in Postmenopausal Women with Metabolic Syndrome. | Metab Syndr Relat Disord | 2023 | 37669459 | PubTator, text mining | PubMed |
| EpCAM, Ki67, and ESM1 Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation. | Appl Immunohistochem Mol Morphol | 2023 | 37668411 | PubTator, text mining | PubMed |
| An integrated analysis of dysregulated SCD1 in human cancers and functional verification of miR-181a-5p/SCD1 axis in esophageal squamous cell carcinoma. | Comput Struct Biotechnol J | 2023 | 37664175 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11082/papers?page=17